Neuphoria Therapeutics (NEUP) Depreciation & Amortization (CF) (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Depreciation & Amortization (CF) of $165,679 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $165,625 a year earlier and unchanged from the prior quarter.
Neuphoria Therapeutics (NEUP) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Neuphoria Therapeutics' Depreciation & Amortization (CF) came in at $662,955, unchanged from FY2025.
- Annual Depreciation & Amortization (CF) shows a three-year compound annual growth rate of 0.0% (FY2023 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Depreciation & Amortization (CF) was $662,890 in FY2025 (unchanged), $662,991 in FY2024 (unchanged) and $663,192 in FY2023.
- Quarterly Depreciation & Amortization (CF) has run from a low of $165,431 in fiscal Q3 2025 to a high of $166,121 in fiscal Q2 2025 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) increased in two of the last eight quarters, with an average year-over-year change of 0.0%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior fiscal quarters was $165,695 (Q3 2026), $165,789 (Q2 2026) and $165,792 (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Neuphoria Therapeutics | 335.34 Mn | 260.15 Mn | - | 165,679.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165,679.00 |
| Mar 31, 2026 | 165,695.00 |
| Dec 31, 2025 | 165,789.00 |
| Sep 30, 2025 | 165,792.00 |
| Jun 30, 2025 | 165,625.00 |
| Mar 31, 2025 | 165,431.00 |
| Dec 31, 2024 | 166,121.00 |
| Sep 30, 2024 | 165,713.00 |
| Jun 30, 2024 | 165,685.00 |
| Mar 31, 2024 | 165,703.00 |
| Dec 31, 2023 | 165,694.00 |
| Sep 30, 2023 | 165,909.00 |
| Dec 31, 2022 | 728,907.87 |
| Dec 31, 2021 | 1.24 Mn |
| Dec 31, 2020 | 1.79 Mn |
Neuphoria Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NEUP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();